Acquiring Company
SAI Parenterals Limited
Acquired Company
Prathyak Laboratories Private Limited
HyderabadHyderabadManufacturingBiotechnologyPharmaceuticalBiotechnologyPharmaceuticalDescription
Sai Parenterals Limited has finalized the acquisition of a 60% equity stake in Prathyak Laboratories for ₹15 crore. This strategic move allows Sai Parenterals to bypass construction risks and gain immediate access to an operational R&D facility. Prathyak Laboratories provides specialized capabilities in drug development that enhance Sai Parenterals' growth strategy. The acquisition strengthens their international expansion efforts, particularly focusing on regulatory compliance for global markets.
Quick answer
SAI Parenterals Limited is acquiring Prathyak Laboratories Private Limited, announced October 5, 2026. SAI Parenterals Limited is based in Hyderabad, Telangana, India.
- How much did SAI Parenterals Limited pay for Prathyak Laboratories Private Limited?
- The deal value was not disclosed.
- What does SAI Parenterals Limited do?
- SAI Parenterals Limited is a mid-sized pharmaceutical manufacturer specializing in injectable and oral dosage forms.
- Where are SAI Parenterals Limited and Prathyak Laboratories Private Limited based?
- SAI Parenterals Limited is based in Hyderabad, Telangana, India. Prathyak Laboratories Private Limited is based in Hyderabad, Telangana, India.
- Who are the decision-makers at SAI Parenterals Limited?
- Fundz holds 2 contacts at SAI Parenterals Limited. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zeria Pharmaceutical acquires Haupt Pharma Wulfling (October 25, 2026)
- Laprophan acquires Corporate Investment Holding (October 21, 2026)
- Senores Pharma acquires 75% stake in Apnar Pharma (August 30, 2026)
- PAI Pharma acquires Nexus Pharmaceuticals (November 12, 2026)
- Lonza to acquire Merck's CDMO unit for €-mid-triple (November 3, 2026)
- eutecma acquires Tempaid for cold chain expansion (September 28, 2026)
Who to call at SAI Parenterals Limited, and when
When SAI Parenterals Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day SAI Parenterals Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SAI Parenterals Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SAI Parenterals Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SAI Parenterals Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Prathyak Laboratories Private Limited?
Prathyak Laboratories Private Limited was acquired by SAI Parenterals Limited, based in Hyderabad. The deal was reported on October 5, 2026. SAI Parenterals Limited is a mid-sized pharmaceutical manufacturer specializing in injectable and oral dosage forms. Founded in 2005, the company has been expanding its capabilities and market reach. SAI Parenterals Limited is privately held and operates in Manufacturing.
When did SAI Parenterals Limited acquire Prathyak Laboratories Private Limited?
SAI Parenterals Limited's acquisition of Prathyak Laboratories Private Limited was reported on October 5, 2026. Sai Parenterals Limited has finalized the acquisition of a 60% equity stake in Prathyak Laboratories for ₹15 crore. This strategic move allows Sai Parenterals to bypass construction risks and gain immediate access to an operational R&D facility. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Prathyak Laboratories Private Limited do?
Prathyak Laboratories Private Limited is a pharmaceutical research and development platform specializing in complex injectables. The company has a strong pipeline with 150 SKUs across 86 molecules. It offers proven expertise in advanced drug delivery systems. It is privately held, operating in Biotechnology, and is based in Hyderabad.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.